Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis.
AZD1163 的临床前表征,AZD1163 是一种用于治疗类风湿性关节炎的首创抗 PAD2/4 双特异性抗体。
期刊:MAbs
影响因子:7.3
doi:10.1080/19420862.2026.2657629
Sims Gary P, Scaletta Lacie, Andrews John, Sims Dorothy A, Strain Martin, Sigurdardottir Anna, Kuriakose Teneema, England Elizabeth, Rajasinghe Lichchavi, Jiang Fanyi, Xiong Ximing, Neal Frances, Vinall Lisa, Newton Philip, Boger Elin, Kim Chong, Dahlbäck Helena, Prothon Susanne, Leander Jacob, Darrah Erika, Collins Mia, Douglas Garry, White Nicholas, Day Katie, Vousden Katherine A, Huntington Catherine E, Close David